Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-8427 vs imipenem/cilastatin in complicated urinary tract infection
CTR20233739Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-8427 in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Hengrui Therapeutics. Started Nov 2023; status: completed.
02
Drugs
HRS-8427
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on CTR20233739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233739.